FDA
approval
· 2013-12-19
FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)
Summary
The FDA approved a supplemental application for escitalopram oxalate from Amneal Pharmaceuticals LLC under ANDA202227, enabling continued commercialization of t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ESCITALOPRAM OXALATE (ESCITALOPRAM)